An NDM-1-producing Escherichia coli obtained in denmark has a genetic profile similar to an NDM-1-producing E. coli isolate from the UK

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue 8, 2012, Pages 2049-2051

  Nielsen, Jesper Boye ^a   Hansen, Frank ^b   Littauer, Pia ^a   Schønning, Kristian ^a   Hammerum, Anette M ^b  

^a HVIDOVRE HOSPITAL   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

Author keywords

MLST; Molecular epidemiology; Plasmids; Resistance mechanisms

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; BACTERIAL PROTEIN; BACTERIAL PROTEIN NDM 1; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COLISTIN; GENTAMICIN; IMIPENEM; MECILLINAM; MEROPENEM; NALIDIXIC ACID; PIPERACILLIN PLUS TAZOBACTAM; STREPTOMYCIN; SULFAMETHOXAZOLE; TETRACYCLINE; TIGECYCLINE; TRIMETHOPRIM; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; DENMARK; ESCHERICHIA COLI; GENE IDENTIFICATION; GENETIC SIMILARITY; HUMAN; LETTER; MINIMUM INHIBITORY CONCENTRATION; NDM 1 PRODUCING ESCHERICHIA COLI; NONHUMAN; PAKISTAN; PHYLOGENETIC TREE; POLYMERASE CHAIN REACTION; TRAVEL; UNITED KINGDOM;

AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CLUSTER ANALYSIS; DENMARK; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; GENES, BACTERIAL; GENOTYPE; GREAT BRITAIN; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; PLASMIDS;

EID: 84864516884     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks149     Document Type: Letter

References (12)

1. Mushtaq S, Irfan S, Sarma JB et al. Phylogenetic diversity of Escherichia coli strains producing NDM-type carbapenemases. J Antimicrob Chemother 2011; 66: 2002-5.
2. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-first Informational Supplement M100-S21. CLSI, Wayne, PA, USA, 2011.
3. Kumarasamy KK, Toleman MA, Walsh TR et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010; 10: 597-602.
4. Hansen DS, Schumacher H, Hansen F et al. Extended-spectrum β-lactamase (ESBL) in Danish clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence, β-lactamase distribution, phylogroups, and co-resistance. Scand J Infect Dis 2012; 44: 174-81.
5. Galimand M, Courvalin P, Lambert T. Plasmid-mediated high-level resistance to aminoglycosides in Enterobacteriaceae due to 16S rRNA methylation. Antimicrob Agents Chemother 2003; 47: 2565-71.
6. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000; 66: 4555-8.
7. Carattoli A, Bertini A, Villa L et al. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods 2005; 63: 219-28.
8. Poirel L, Lagrutta E, Taylor P et al. Emergence of metallo-β-lactamase NDM-1-producing multidrug-resistant Escherichia coli in Australia. Antimicrob Agents Chemother 2010; 54: 4914-6.
9. Pfeifer Y, WitteW, Holfelder M et al. NDM-1-producing Escherichia coli in Germany. Antimicrob Agents Chemother 2011; 55: 1318-9.
10. Mulvey MR, Grant JM, Plewes K et al. New Delhi metallo-β-lactamase in Klebsiella pneumoniae and Escherichia coli, Canada. Emerg Infect Dis 2011; 17: 103-6.
11. Peirano G, Ahmed-Bentley J, Woodford N et al. New Delhi metallo-β-lactamase from traveler returning to Canada. Emerg Infect Dis 2011; 17: 242-4.
12. NDM-1-positive IncA/C plasmid from Escherichia coli ST38 isolate suggests a possible origin from plant pathogens. PLoS One 2011; 6: e25334.